List of Vendor Companies in Taiwan - 8

Abnova is the first biotech company successfully integrated the IT-style management and industrial-scale antibody manufacturing. Our goal is to have at least one antibody to every human expressed gene in human genome. In Phase I of our business plans, we vastly expand the scope and availability of antibody reagents for the research market by taking a genome-wide approach to the high throughput production of human protein and antibody. There products are marketed through a combination of E-commerce based direct sales and a multi-tiered, sales network of over 49 distributors around the world. Starting from Year 2009 to 2013, in Phase II of the business plans, we have diversified into the systems arena focusing on antibody pairs, ELISA kits and instrumentation for rare cell isolation. In Phase III, we focus on in vitro diagnostics development concentrating on non-invasive, liquid biopsies of circulating tumor cells, ctDNA, and exosomes for precision medicine. Now in Phase IV (Year 2017 and later), we have focused on drug development specializing on immunotherapy. The value-added business has set the path of company's future growth and provided opportunity for Abnova to contribute to the biotech industry at large. We welcome researchers, biotech, and pharmaceutical companies to work with us and succeed together!

ACRO Biomedical was founded in June 2014 in Kaohsiung, Taiwan, by Dr. Dar-Jen Hsieh and a group of scientists and physicians. ACRO Biomedical develops and produces biomaterial medical devices for human tissue engineering and regenerative medicine (TERM). ACRO Biomedical uses its proprietary supercritical CO₂ extraction technology to remove cells, fat and non-collagenous proteins from animal tissues, while keeping the undiminished collagen scaffold as the biomaterial for high-end medical devices in the medical regenerative field of wound care, orthopedics, dentistry, ophthalmology, aesthetic microsurgery, cardiovascular and neural surgery, etc.

Atgenomix is a data and machine learning (ML) company that provides an open standard and unified platform for operationalizing biomedical data, analytics, and ML to deliver on the promise of precision medicine. The Atgenomix cloud-based biomedical informatics platform empowers clinical laboratories to design, develop, and operate GA4GH (Global Alliance for Genomics & Health) standard orchestrated multimodal workflows of data integration, tool engineering, analysis automation, workload acceleration, and regulatory compliance management. At Atgenomix, we envision a technology that will transform healthcare in routine clinical genomics and artificial intelligence. We aim to provide industry accessible computational lab technologies that researchers need to scale data and machine learning in the future. Atgenomix is a Microsoft Azure cloud partner in gold data and cloud platform competencies, and a Google Health trusted partner in genomics research.

Based on the unique technology of simplifying, optimizing, and realizing the comprehensive genomics analysis algorithm, we deliver the hardware-accelerated genomic data analysis solution.

Genomics Bioscience and Technology Co., Ltd. is Taiwan's leading commercial genome sequencing company. Our diverse services encompass comprehensive gene sequencing technology and applications and oligonucleotide and peptide synthesis, meeting standards from RUO to GMP compliance. Committed to excellence, we collaborate with prestigious academic institutions and biotech companies to advance precise medical genetic testing and champion personalized precision medicine. With over 20 years of expertise and academic experience in the biotechnology field, we are equipped with state-of-the-art technology, including the Illumina Novaseq X Plus. We offer a comprehensive NGS workflow from sample preparation to bioinformatics analysis. Our dedicated goal is to support our partners in advancing Taiwan's biotechnology sector onto the international stage and highlighting the robust strength of Taiwan's biological sciences to the world. With Taiwan as our home base, we are set to make strides on the global stage.

Micronbrane Medical develops genomic innovations that enrich our understanding of microorganisms that influence human health and ensure sustainability. The company's proprietary technologies include special collection devices, novel host depletion, optimized reagents, advanced metagenomic sequencing assays, plus rapid bioinformatic analysis software. The combined Micronbrane Medical solution enables fast and accurate identification and monitoring of a broad range of microorganisms, including bacteria, fungi, viruses, and parasites. Headquartered in Taiwan, the company has partnerships and collaborations with leading academic institutions, health systems, and clinical laboratories worldwide, underscoring its commitment to transforming our interactions with the microbial world. For more information visit https://micronbrane.com/

MyHeritage is the leading global discovery platform for exploring family history. With billions of historical records and family tree profiles, and with sophisticated matching technologies that work across all its assets, MyHeritage allows users to discover their past and empower their future. MyHeritage DNA is one of the world’s largest consumer DNA databases, with 5.4 million customers. MyHeritage is the most popular DNA test and family history service in Europe. Since 2020, MyHeritage is home to the world’s most advanced AI technologies for repairing, enhancing, colorizing, and animating historical photos. Working at MyHeritage means developing pioneering technologies and integrating AI to deliver powerful discoveries to our 104 million users. It also means making a difference in the lives of people all over the world. With a track record of leveraging its staff and expertise to help communities around the world, in April 2020, MyHeritage joined the fight against COVID-19 by building one of the world's largest COVID-19 laboratories to dramatically scale up Israel's testing capabilities and save lives. The MyHeritage Lab was commissioned by Israel’s Ministries of Health and Defense, and to date has processed over 5 million tests. Our 650 employees enjoy a hybrid work model that combines the convenience and flexibility of working from home with the collaborative social environment of our bright, spacious offices. Headquartered in Or Yehuda, we also have offices in Tel Aviv, North America, and Europe. When we’re not working, you can find us enjoying the fully-stocked kitchens, office gym, yoga classes, happy hours, and team-building activities. Visit our careers site for more information about our open positions: http://careers.myheritage.com

Develops Opto-Electronic Single Molecule Sequencing